Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
RxSight, Inc. - Common Stock
(NQ:
RXST
)
25.05
-1.51 (-5.69%)
Streaming Delayed Price
Updated: 1:03 PM EDT, Mar 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RxSight, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 25, 2025
From
RxSight, Inc.
Via
GlobeNewswire
The Analyst Verdict: RxSight In The Eyes Of 9 Experts
March 19, 2025
Via
Benzinga
Expert Outlook: RxSight Through The Eyes Of 11 Analysts
February 26, 2025
Via
Benzinga
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance
February 25, 2025
From
RxSight, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 25, 2025
February 25, 2025
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For RxSight
December 20, 2024
Via
Benzinga
Analyst Scoreboard: 7 Ratings For RxSight
October 29, 2024
Via
Benzinga
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
September 13, 2024
Via
Benzinga
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
February 11, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
January 12, 2025
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
January 02, 2025
From
RxSight, Inc.
Via
GlobeNewswire
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
August 06, 2024
Via
Benzinga
RxSight Analysts Slash Their Forecasts After Q2 Results
August 06, 2024
Via
Benzinga
RXST Stock Earnings: RxSight Beats Revenue for Q2 2024
August 05, 2024
RXST stock results show that RxSight beat on revenue for the second quarter of 2024.
Via
InvestorPlace
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
July 15, 2024
Via
Benzinga
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
December 20, 2024
Via
Benzinga
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
December 11, 2024
Via
Benzinga
RxSight, Inc. Reports Third Quarter 2024 Financial Results
November 07, 2024
From
RxSight, Inc.
Via
GlobeNewswire
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 29, 2024
Via
Benzinga
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
October 24, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
August 22, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight Stock Sees Relative Strength Rating Rise To 91
August 19, 2024
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91.
Via
Investor's Business Daily
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
August 06, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 06, 2024
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday!
Via
InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
August 06, 2024
Via
Benzinga
RxSight, Inc. Reports Second Quarter 2024 Financial Results
August 05, 2024
From
RxSight, Inc.
Via
GlobeNewswire
The 3 Best Med Tech Stocks to Buy Now
August 05, 2024
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now.
Via
InvestorPlace
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
July 22, 2024
From
RxSight, Inc.
Via
GlobeNewswire
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
Via
Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 10, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.